Clinical Trial of TN-201 Showed Encouraging Safety Profile, Transduction and Expression, Plus Improvements in Hypertrophy and ...

The Family Heart Foundation, a leading research and advocacy organization focused on the role of lipids in cardiovascular ...

Aortic aneurysms — dangerous bulges in the body’s main artery, the aorta — are becoming increasingly common as more people ...

WEDNESDAY, May 7, 2025 (HealthDay News) -- Persistently high blood sugar among teenagers can lead to heart disease by young ...

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection-even when standard medical tests return normal ...

Observational studies at the SCAI meeting favored the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound) over ...

The development of novel therapeutics offers great hope for the fight against widespread diseases such as cancer, but they ...

One person dies every 33 seconds from heart disease, according to the Centers for Disease Control and Prevention.

These heart cells rupture and leak DNA, which sparks a damaging immune response. This breakthrough challenges long-held ...

Hypertension can cause heart problems and strokes. Reducing high blood pressure can reduce the risk of both. Heart disease is ...

An Israeli study has identified TRIM63 as a significant genetic contributor to hypertrophic cardiomyopathy – the most common ...

To REMS, or not to REMS. That, apparently, was the question for Cytokinetics, which has seen any potential approval for its ...